Table 3.

Ratio of N-glycan of BALB/c mouse serum in experiments I, II and III.

N-glycan type %	BALB/c-CNT	BALB/c T. gondii (40 dpi)	BALB/c T. gondii (10 dpi)	BALB/c 1-MT	1-MT + BALB/c T. gondii (10 dpi)	SCID-CNT	SCID T. gondii (10 dpi)
High-man%	13%	11%	12%	11%	13%	11%	14%
Hybrid%	38%	33%	35%	33%	38%	33%	36%
Complex%	50%	56%	53%	56%	50%	56%	50%

Experiment-I [BALB/c-control, and BALB/c- exposed to chronic T. gondii], experiment-II [BALB/c-control, BALB/c- exposed to acute T. gondii, 1-MT, and BALB/c- treated with 1-MT after exposure to acute T. gondii], experiment-III [BALB/c-control, BALB/c- exposed to acute T. gondii, SCID-control, and SCID-exposed to acute T. gondii]. 1-MT: 1-methyl tryptophan; CNT: control; SCID: severe combined immune deficiency, and SD: standard deviation.